Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia

Author： Pordzik Sandra Petrovici Karin Schmid Christoph Kroell Tanja Schweiger Cornelia Köhne Claus-Henning Schmetzer Helga

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.16, Iss.6, 2011-11, pp. : 341-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia

By Lewis N.R. Pallis M. Russell N.H.

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis - analysis of 141 cases

By Lickliter J.D. Kratzke R.A. Nguyen P.L. Niehans G.A. Miller J.S.

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1519-1527

Elsevier

Access to resources Recommend Favorite

Assessment of Bcl-2 Expression as Modulator of Fas Mediated Apoptosis in Acute Leukemia

By Aref S. Salama O. Al-Tonbary Y. Mansour A.

Hematology, Vol. 9, Iss. 2, 2004-04 ,pp. : 113-121

Maney Publishing

Access to resources Recommend Favorite

Expression of Fas Ligand and Its Receptor in Cutaneous Lupus: Implication in Tissue Injury

By Nakajima M. Nakajima A. Kayagaki N. Honda M. Yagita H. Okumura K.

Clinical Immunology, Vol. 83, Iss. 3, 1997-06 ,pp. : 223-229

Academic Press

Access to resources Recommend Favorite

Prognostic significance of Fas expression in retinoblastoma

By Shanmugam Mahesh P. Lakshmi S Amirtha Biswas Jyotirmay Krishnakumar S.

Ocular Immunology and Inflammation, Vol. 11, Iss. 2, 2003-06 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite